248 related articles for article (PubMed ID: 6853199)
1. Dose revision for A-bomb survivors and the question of fallout contribution.
Schmitz-Feuerhake I
Health Phys; 1983 Jun; 44(6):693-5. PubMed ID: 6853199
[No Abstract] [Full Text] [Related]
2. [Dose-effect relationships in Hiroshima and Nagasaki and the evaluation of radiation risks taking into account the fallout dose].
Schmitz-Feuerhake I; Carbonell P; Wellner R
Strahlenschutz Forsch Prax; 1985; 25():229-37. PubMed ID: 21452582
[No Abstract] [Full Text] [Related]
3. "Radiation-induced" cancer.
Cember H
Science; 1989 Sep; 245(4922):1031-2. PubMed ID: 2772653
[No Abstract] [Full Text] [Related]
4. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
5. Studies of the mortality of A-bomb survivors. 4. Mortality and radiation dose, 1950-1966.
Beebe GW; Kato H; Land CE
Radiat Res; 1971 Dec; 48(3):613-49. PubMed ID: 5137468
[No Abstract] [Full Text] [Related]
6. [Biological effects and mortality in connection with low dosage ionizing radiation].
Henriksen JH
Ugeskr Laeger; 2001 Jan; 163(1):44-5. PubMed ID: 11586674
[No Abstract] [Full Text] [Related]
7. Leukaemic mycosis fungoides in an atomic bomb survivor with lung and renal cancers.
Shimauchi T; Nishio D; Isoda H; Sugita K; Kabashima K; Tokura Y
Clin Exp Dermatol; 2009 Oct; 34(7):e322-4. PubMed ID: 19456778
[No Abstract] [Full Text] [Related]
8. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
[TBL] [Abstract][Full Text] [Related]
9. A-bomb data: detection of bias in the Life Span Study cohort.
Stewart A
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1519-21. PubMed ID: 9467075
[TBL] [Abstract][Full Text] [Related]
10. Unilateral multiple primary tumours in an atomic-bomb survivor.
Morishita M; Ohtsurut A; Nakashima M; Yamashita S
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):391-2. PubMed ID: 16097573
[TBL] [Abstract][Full Text] [Related]
11. NCI apologizes for fallout study delay.
Wadman M
Nature; 1997 Oct; 389(6651):534. PubMed ID: 9335478
[No Abstract] [Full Text] [Related]
12. Thoughts on the nuclear age.
Thompson RH
Ohio State Med J; 1983 Jun; 79(6):403, 405, 407. PubMed ID: 6634010
[No Abstract] [Full Text] [Related]
13. [Health effects of atomic bomb radiation].
Shigematsu I
Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
[TBL] [Abstract][Full Text] [Related]
14. Profiles of non-cancer diseases in atomic bomb survivors.
Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumors following fallout radiation exposure.
Adams WH; Harper JA; Rittmaster RS; Grimson RC
JAMA; 1984 Aug; 252(5):664-6. PubMed ID: 6737672
[TBL] [Abstract][Full Text] [Related]
16. Radiation from bomb tests could cause thyroid cancer, but screening program not advisable. US National Academy Press.
J Radiol Prot; 1998 Dec; 18(4):303-4. PubMed ID: 9915646
[No Abstract] [Full Text] [Related]
17. Salivary gland tumors among atomic bomb survivors, 1950-1987.
Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
[TBL] [Abstract][Full Text] [Related]
18. Study focuses on genetic fallout of the bomb.
Cyranoski D
Nature; 2001 Jan; 409(6816):5. PubMed ID: 11343078
[No Abstract] [Full Text] [Related]
19. [The distinctive characteristics of malignant neoplasms in the population of the Altai Territory subjected to long-term radiation exposure as a consequence of the multiyear nuclear explosives tests at the Semipalatinsk proving ground].
Lazarev AF; Shoĭkhet IaN; Petrova VD
Vopr Onkol; 1995; 41(2):23-5. PubMed ID: 7483423
[No Abstract] [Full Text] [Related]
20. Risks from depleted uranium.
Jones S; Lowles I; Smith A
Lancet; 2001 May; 357(9267):1532. PubMed ID: 11383545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
